BMEDvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with BMED, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BMED performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/01/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BMED ETF 2 | +9.94%– | +19.78%– | +12.35%– | +29.36%– | +41.24%– | +10.84%– |
| Flows | BMED ETF 2 | +$1M– | +$1M– | +$5M– | +$7M– | +$7M– | +$6M– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BMED ETF 2 | +21.97%– | +17.43%– | +16.63%– | +18.01%– |
| Max drawdown | BMED ETF 2 | -4.62%– | -14.71%– | -19.76%– | -33.96%– |
| Max drawdown duration | BMED ETF 2 | 32d– | 196d– | 237d– | 1586d– |
Trading data
BMED | ETF 2 | |
Last sale 9/2/2026 at 1:30 PM | $34.28 | – |
| Previous close 09/01/2026 | $33.91 | – |
| Consolidated volume 09/01/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 9/2/2026 at 1:30 PM
Live
Closed
BMED | ETF 2 | |
|---|---|---|
| Last price | $34.28 | – |
| 1D performance | +1.10% | – |
| AuM | $13.57 M | – |
| E/R | 0.77% | – |
Characteristics
BMED | ETF 2 | |
|---|---|---|
| Management strategy | Active | – |
| Provider | iShares | – |
| Benchmark | - | – |
| N° of holdings | 53 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 29, 2020 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
BMED
USA
86.04%
Other
13.96%
ETF 2
Sectors
BMED
Healthcare
95.69%
Other
4.31%
ETF 2
Advertisement
Diversification
BMED
Total weight of top 15 holdings out of 15
56.15%
ETF 2
–
Top 15 holdings
Data as of July 31, 2026
BMED
Merck & Co., Inc.
5.85%
Gilead Sciences, Inc.
4.87%
Johnson & Johnson
4.45%
Edwards Lifesciences Corp.
4.43%
Thermo Fisher Scientific, Inc.
4.17%
Charles River Laboratories International, Inc.
3.72%
Danaher Corp.
3.63%
Biogen, Inc.
3.58%
Waters Corp.
3.50%
AbbVie, Inc.
3.50%
Mettler-Toledo International, Inc.
3.37%
Moderna, Inc.
3.07%
Vertex Pharmaceuticals, Inc.
2.96%
BlackRock Cash Funds - Treasury
2.58%
Amgen, Inc.
2.49%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
